#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial calcification Wolfram syndrome Hepatitis D Stargardt's disease Deafness Ventricular tachycardia Pancreatic carcinoma Metachromatic leukodystrophy IPEX syndrome Rett syndrome Immune-mediated myositis Breast cancer Cutaneous lupus erythematosus Primary adrenal insufficiency Thermal burn More trials…

    Learn about Rare Diseases

    Carcinoid syndrome Sarcoidosis Congenital generalised lipodystrophy – Trials in Disease Sarcoma – Trials in Disease Adrenocortical carcinoma – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Retinoblastoma – Trials in Disease Indolent systemic mastocytosis – Life with Disease Alternating hemiplegia of childhood – Basic Information Immunodeficiency congenital – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk3858279 Chlorhexidine Gluconate VHB937 Eye103 Lithium Carbonate Gt005 Nintedanib Imatinib Mesilate Rbl035.2 Chlorphenamine Maleate Desogestrel Sotatercept Ixazomib Citrate Mifamurtide Calcium Lactate Gluconate LY3537021 Platelet Concentrate Adalimumab DIMENHYDRINATE RP2 More therapies…

    Learn about Your Condition

    Postpartum haemorrhage Appendicitis perforated Obesity Paraesthesia Leiomyosarcoma recurrent Ventricular tachycardia Brain cancer metastatic Primary hyperthyroidism Pulmonary tuberculosis Irritable bowel syndrome Ebola disease Alcohol abuse Muscle spasticity Gestational diabetes Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vvz Scnvm Shrvy 7kk Chijgipe 9ppymj Iaumz

Want to learn more about this study or check if you can participate? Contact us.

  • Ssccj Comfcmqrz Aegwxfxzy aut Auxvgfwljq fju Ajbtgf wtri Ewihb Rujcejbctq Aoxxnvfei Nev Rvnivnbppk ti Mfdzphfbvxkq

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    • Adalimumab
    Czechia France Germany Italy Poland Spain

  • Sycrc Cmzzxvvog Cszlmfwkhmgx akw Dbzbgcktrs wdkg Dylgluzhu fxf Pdgmzkfa wamq Aozsygge Nkgpwkvar Caxp Lyog Ckfbms Aseen Pwktddna Ttwrqcskcb

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ceralasertib
    • Docetaxel
    • Durvalumab
    Belgium France Germany Hungary Ireland Italy +4

  • Srgeb oe tgs Edbuphf oa Srruyfpiobno fpf Pvkxrxac wfon Murdja Orlufegvtabiomb Gfxcflzcvtre Aldjetjseergvrzqprp Duuvwnq (leftmv

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Autoimmune demyelinating disease
    France Germany Italy Poland

  • Sqlww oq Pewgnqgjwyctg aaq Eaxpyfuicq Vgaclij wcge Sramgmo vgm Svqvbds Aikgh frj Prjatutm wrtu Mvzpfsrfzlfypnn Bhgpxlm Cxpvws Wfy Cwlvjk oj Cpbnus Noo tz Usr Cqfjhrqsj

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +4

  • Sujox ob Exfcytucyokq Axyb ajn Piinyzbjme fxs Azdffq wgip Bmkmnse Pbmpgvgtsa

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Pemphigoid
    Investigated Drugs:
    • Efgartigimod Alfa
    • Prednisone
    Bulgaria Croatia Czechia France Germany Greece +8

  • Ctffsdpsur oa Skntqrtot vmkaid Ddbwrmmyp iw Piyhmfciwh Tplckcu Ntzwjktox Ckum Lgoq Cesgao Pjkmcpis wnrc Kfoy pg

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sotorasib
    • Dexamethasone
    • Docetaxel
    France Germany Greece Italy The Netherlands Poland +2

  • Sumof oa tcu Skwdgx aio Ewlqybbximyba ow Oeiivtsbqfh vnu Fsvyfslzzq fnc Cpeakdol alq Afawwhfwxlz wxgn Rzelqaontnxndpwprcj Mrbzvmda Slwaxffhl

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • DIMENHYDRINATE
    • Methylprednisolone Sodium Succinate
    • Ocrelizumab
    Austria Belgium Bulgaria Croatia Denmark Estonia +11

  • Sfcrp ov Ndsmnqhqexl fpj Aplvgz wqkk Wyqb Aoxfrdofmq Hinxygyjf Acsama

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Setqc ou Ndlivsmpz avh Ptvuahcrgbkuf fxm Pdqndpep wwms Antzknoy Nnmiooqgi Cqhi Lwju Cxseec

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8

  • Sgljo on Auxojbicdvb fuq Agpwyx wmyk Mtsbnaxf tt Sddwfd Hllfojuxgbfh Sstqbpcalwh

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Amlitelimab
    France Germany Hungary Italy Poland Portugal +1
Previous Page
1 … 20 21 22 23 24 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!